Journey Medical Corporati... (DERM)
NASDAQ: DERM
· Real-Time Price · USD
7.00
-0.26 (-3.58%)
At close: Aug 15, 2025, 3:08 PM
Journey Medical Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -4.07M | 1.52M | -2.39M | -3.36M | -10.44M | -2.14M | 16.79M | -8.36M | -10.14M | -10.64M | -10.08M | -7.53M | -1.38M | -21.75M | -10.65M | -11.87M | 268K |
Depreciation & Amortization | 1.09M | 1M | 837K | 839K | 836K | 838K | 836K | 1.09M | 1.09M | 1.25M | 1.04M | 1.04M | 1.04M | 513K | 680K | 762K | 605K |
Stock-Based Compensation | 1.32M | 1.38M | 1.64M | 1.67M | 1.41M | 529K | 558K | 873K | 646K | 1.44M | 1.44M | 774K | 773K | 2.42M | 8K | 11K | 22K |
Other Working Capital | 6.24M | -279K | 1.37M | -3.94M | 873K | 1.58M | -5.95M | 6.76M | -8.44M | -389K | -1.74M | -6.2M | 3.81M | -2.37M | -11.98M | 15M | 37K |
Other Non-Cash Items | 296K | -213K | -367K | 210K | 68K | 19.42M | 235K | 357K | 241K | 441K | 218K | 262K | 141K | 4.28M | 11.07M | 4.87M | 291K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | -19.48M | -82K | 3.59M | n/a | n/a | n/a | n/a | n/a | 8.27M | -3.36M | -3.41M | 69K |
Change in Working Capital | -1.46M | -1.46M | -877K | -4.54M | 3.11M | -15.69M | 411K | 6.42M | 7.2M | 3.68M | 48K | 2.15M | 309K | 3.06M | 9.35M | 2.19M | 106K |
Operating Cash Flow | -2.83M | 2.23M | -1.16M | -5.18M | -5.02M | -16.52M | 18.75M | 3.97M | -956K | -3.84M | -7.28M | -3.3M | 884K | -3.21M | 7.1M | -7.44M | 1.36M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | 5M | n/a | n/a | -5M | -20M | n/a | n/a | -20M | -1.2M | -8.8M | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | -15M | n/a | n/a | n/a | n/a | n/a | n/a | -5M | 20M | n/a | n/a | -20M | -1.2M | -8.8M | n/a | n/a |
Investing Cash Flow | n/a | -15M | n/a | n/a | n/a | 5M | n/a | n/a | -5M | -20M | n/a | n/a | -20M | -1.2M | -8.8M | n/a | n/a |
Debt Repayment | -625K | -4.33M | -675K | 5M | n/a | 15M | -11M | -13M | 52K | -2M | 4M | n/a | 11.95M | 812K | 7.04M | -1M | -1.8M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -371K | -1.55M | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -365K | n/a | n/a |
Other Financial Acitivies | n/a | 16.62M | 187K | n/a | 153K | -471K | n/a | -88K | n/a | 2.95M | 31K | 111K | -585K | 30.99M | -99K | -179K | -1.35M |
Financial Cash Flow | 3.6M | 10.62M | -294K | 5.03M | 1.64M | 19.12M | -10.98M | -13.09M | 52K | 948K | 4.03M | 111K | 11.37M | 31.8M | 11.21M | 616K | 9.39M |
Net Cash Flow | 765K | -2.16M | -1.45M | -145K | -3.38M | 2.69M | 7.77M | -9.12M | -5.9M | -2.89M | -3.25M | -3.19M | -7.75M | 27.39M | 9.51M | -6.82M | 10.75M |
Free Cash Flow | -2.83M | 2.23M | -1.16M | -5.18M | -5.02M | -11.43M | 18.75M | 3.97M | -5.96M | -23.84M | -7.28M | -3.3M | -19.12M | -4.41M | -1.7M | -7.44M | 1.36M |